Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Boehringer Ingelheim China Biopharmaceuticals Project, Shanghai

Project Type

Biopharmaceuticals facility

Location

Shanghai, China

Construction Started

June 2013

Estimated Investment

€70m ($76m approximately)

Completion

May 2017 (phase one)

Developer

Boehringer Ingelheim

Contractors

NNE and Archetype Group
Expand

Go Top